TUESDAY, Jan. 7, 2025 -- For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious...
Vous n'êtes pas connecté
The impact of Ozempic and other GLP-1 receptor agonists like Wegovy, Mounjaro, and Zepbound on the alcohol and wine industry appears to be multifaceted, with several studies and anecdotal evidence suggesting a potential decrease in alcohol consumption among users of these drugs. Here’s a detailed analysis: Reduced Alcohol Consumption Studies and reports have highlighted that […]
TUESDAY, Jan. 7, 2025 -- For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious...
Junk food companies are starting to get nervous over how many Americans use GLP-1 medications to lose weight. Washington Post columnist Catherine...
Highlights: Up to 30% of weight lost with GLP-1 drugs like Ozempic comes from muscle and bone mass, not fat
The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients' access to anti-obesity drugs such as...
FRIDAY, Jan. 10, 2025 -- Ozempic? Wegovy? Zepbound? How about elderberry juice? Elderberry juice might help people lose weight and improve their blood...
FRIDAY, Jan. 10, 2025 -- Ozempic? Wegovy? Zepbound? How about elderberry juice? Elderberry juice might help people lose weight and improve their blood...
Eli Lilly's Zepbound is set to dominate the global obesity market, offering new hope with its groundbreaking treatment for weight management.
Can Ozempic and similar drugs cause muscle and bone loss? Discover how to maintain your health while achieving weight loss goals with GLP-1...
Explore how immuno-oncology drugs are transforming cancer treatment and discover the rising trend of anti-obesity drugs in the pharmaceutical...
THURSDAY, Jan. 2, 2024 -- Weight loss tops many folks’ list of New Years resolutions, and lots of people are turning to cutting-edge weight-loss...